KLRA: the balance sheet

MyFinsight

Kailera Therapeutics, Inc. (KLRA)

For the quarter ending 2026-03-31, KLRA has $624,756K in assets. $64,480K in debts. $111,826K in cash and cash equivalents.

Balance Sheets	2026-03-31
Cash and cash equivalents	111,826
Marketable securities	407,348
Prepaid expenses and other current assets	11,141
Total current assets	530,315
Property and equipment, net	1,854
Restricted cash	761
Long-term marketable securities	62,747
Non-current clinical deposits	13,318
Operating lease right-of-use assets	10,170
Other non-current assets	5,591
Total assets	624,756

Accounts payable	7,095
Accrued expenses and other current liabilities	46,714
Operating lease liabilities, current	1,027
Total current liabilities	54,836
Operating lease liabilities, non-current	9,443
Other non-current liabilities	201
Total liabilities	64,480
Convertible preferred stock-Series AConvertible Preferred Stock	390,306
Convertible preferred stock-Series BConvertible Preferred Stock	602,058
Common stock	0
Additional paid-in capital	15,977
Accumulated other comprehensive (loss) income	-532
Accumulated deficit	-447,533
Total stockholders' deficit	-432,088
Total liabilities, convertible preferred stock and stockholders' deficit	624,756

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.